切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2017, Vol. 11 ›› Issue (04) : 193 -197. doi: 10.3877/cma.j.issn.1674-0807.2017.04.001

指南与共识

乳腺癌荧光示踪前哨淋巴结活组织检查操作指南
中华医学会肿瘤学分会乳腺癌学组   
  • 收稿日期:2017-04-21 出版日期:2017-08-01

Guidelines for fluorescence-guided sentinel node biopsy

  • Received:2017-04-21 Published:2017-08-01
引用本文:

中华医学会肿瘤学分会乳腺癌学组. 乳腺癌荧光示踪前哨淋巴结活组织检查操作指南[J/OL]. 中华乳腺病杂志(电子版), 2017, 11(04): 193-197.

[1]
王殊, 杨德起, 佟富中, 等. 自发荧光物质吲哚菁绿在乳腺癌前哨淋巴结活检的应用[G]/ /中华医学会肿瘤学分会第七届全国中青年肿瘤学术会议——中华医学会肿瘤学分会“中华肿瘤明日之星”大型评选活动暨中青年委员全国遴选论文汇编. 济南:[出版者不详],2011.
[2]
郭嘉嘉, 杨厚圃, 周礼馨, 等. 自发荧光物质在前哨淋巴结活检中的应用[J]. 中国肿瘤临床,2011,28(22):1397-1399.
[3]
黄林平,刘军. 荧光法前哨淋巴结活检在早期乳腺癌中的应用(附文献复习)[J]. 中日友好医院学报,2013,27(4):195-199.
[4]
曹迎明, 王殊, 郭嘉嘉, 等. 吲哚菁绿联合美蓝在乳腺癌前哨淋巴结活检术中的应用[J]. 中华普通外科杂志, 2014, 29(2):119-122.
[5]
郭文斌, 高伟, 刘金涛, 等. 吲哚菁绿荧光导航技术在乳腺癌前哨淋巴结活检中的应用[J]. 中国普通外科杂志, 2015,24(5):658-662.
[6]
寇德强, 邱镜丹, 王全胜, 等. 吲哚菁绿在乳腺癌前哨淋巴结活检中的应用观察[J]. 解放军医学杂志,2015,40(5):392-395.
[7]
李传书. 吲哚菁绿与亚甲蓝在乳腺癌前哨淋巴结活检术中应用的对比研究[J]. 医学与哲学,2015,31(1B):31-32.
[8]
龚晓军, 毛红岩, 刘慧民,等. 吲哚菁绿荧光法在乳腺癌前哨淋巴结活检中的应用[J]. 中国普外基础与临床杂志,2016,23(2):221-224.
[9]
张贾震男,欧江华, 张晨光,等. 联合吲哚菁绿荧光法与蓝染法行乳腺癌前哨淋巴结活检的临床研究[J]. 中国普通外科杂志,2016,25(5):705-710.
[10]
苑龙, 周艳, 胡滢, 等. 吲哚菁绿联合亚甲蓝在乳腺癌前哨淋巴结活组织检查中的应用价值[J/CD]. 中华乳腺病杂志(电子版),2016,10(2):87-91.
[11]
张泽淳, 谢派泽, 陈捷鑫,等. 吲哚菁绿联合美蓝在乳腺癌腋窝前哨淋巴结活检的临床应用价值[J]. 中国肿瘤临床,2016,43(17):757-760.
[12]
Kitai T, Inomoto T, Miwa M, et al. Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer[J]. Breast Cancer,2005,12(3):211-215.
[13]
Tagaya N, Yamazaki R, Nakagawa A, et al. Intraoperative identification of sentinel lymph nodes by near-infrared fluorescence imaging in patients with breast cancer [J]. Am J Surg,2008,195(6):850-853.
[14]
Murawa D, Hirche C, Dresel S, et al. Sentinel lymph node biopsy in breast cancer guided by indocyanine green fluorescence[J]. Br J Surg,2009,96(11):1289-1294.
[15]
van der Pas MH, van Dongen GA, Cailler F, et al. Sentinel node procedure of the sigmoid using indocyanine green: feasibility study in a goat model[J]. Surg Endosc,2010,24(9):2182-2187.
[16]
Hirche C, Murawa D, Mohr Z,et al. ICG fluorescence-guided sentinel node biopsy for axillary nodal staging in breast cancer[J]. Breast Cancer Res Treat,2010,121(2):373-378.
[17]
Hojo T, Nagao T, Kikuyama M, et al. Evaluation of sentinel node biopsy by combined fluorescent and dye method and lymph flow for breast cancer[J]. Breast,2010,19(3):210-213.
[18]
Tagaya N, Aoyagi H, Nakagawa A, et al. A novel approach for sentinel lymph node identification using fluorescence imaging and image overlay navigation surgery in patients with breast cancer [J]. World J Surg,2011,35(1):154-158.
[19]
Mieog JS, Troyan SL, Hutteman M, et al. Toward optimization of imaging system and lymphatic tracer for near-infrared fluorescent sentinel lymph node mapping in breast cancer [J]. Ann Surg Oncol,2011,18(9):2483-2491.
[20]
Hutteman M, Mieog JS,van der Vorst JR, et al. Randomized,doubleblind comparison of indocyanine green with or without albumin premixing for near-infrared fluorescence imaging of sentinel lymph nodes in breast cancer patients[J]. Breast Cancer Res Treat,2011,127(1):163-170.
[21]
Polom K,Murawa D,Rho Y,et al. Current trends and emerging future of indocyanine green usage in surgery and oncology: a literature review[J]. Cancer,2011,117(21):4812-4822.
[22]
Aoyama K, Kamio T, Ohchi T, et al. Sentinel lymph node biopsy for breast cancer patients using fluorescence navigation with indocyanine green[J]. World J Surg Oncol,2011,9:157.
[23]
Hirche C, Mohr Z, Kneif S, et al. High rate of solitary sentinel node metastases identification by fluorescence-guided lymphatic imaging in breast cancer[J]. J Surg Oncol,2012,105(2):162-166.
[24]
Alander JT, Kaartinen I, Laakso A, et al. A review of indocyanine green fluorescent imaging in surgery [J]. Int J Biomed Imaging,2012,2012:940 585.
[25]
Yuasa Y, Seike J, Yoshida T, et al. Sentinel lymph node biopsy using intraoperative indocyanine green fluorescence imaging navigated with preoperative CT lymphography for superficial esophageal cancer [J].Ann Surg Oncol,2012,19(2):486-493.
[26]
Polom K, Murawa D, Rho YS, et al. Skin melanoma sentinel lymph node biopsy using real-time fluorescence navigation with indocyanine green and indocyanine green with human serum albumin[J]. Br J Dermatol,2012,166(3):682-683.
[27]
Polom K, Murawa D, Nowaczyk P, et al. Breast cancer sentinel lymph node mapping using near infrared guided indocyanine green and indocyanine green-human serum albumin in comparison with gamma emitting radioactive colloid tracer [J]. Eur J Surg Oncol, 2012,38(2):137-142.
[28]
Brouwer OR, Klop WM, Buckle T, et al. Feasibility of sentinel node biopsy in head and neck melanoma using a hybrid radioactive and fluorescent tracer [J]. Ann Surg Oncol,2012,19(6):1988-1994.
[29]
Fujisawa Y, Nakamura Y, Kawachi Y, et al. Indocyanine green fluorescence-navigated sentinel node biopsy showed higher sensitivity than the radioisotope or blue dye method, which may help to reduce false-negative cases in skin cancer[J]. J Surg Oncol,2012, 106(1):41-45.
[30]
Sano K, Mitsunaga M, Nakajima T, et al. In vivo breast cancer characterization imaging using two monoclonal antibodies activatably labeled with near infrared fluorophores [J]. Breast Cancer Res,2012,14(2):R61.
[31]
van den Berg NS, Brouwer OR, Klop WM, et al. Concomitant radioand fluorescence-guided sentinel lymph node biopsy in squamous cell carcinoma of the oral cavity using ICG-(99m)Tc-nanocolloid[J]. Eur J Nucl Med Mol Imaging,2012,39(7):1128-1136.
[32]
Wishart GC, Loh SW, Jones L, et al. A feasibility study (ICG-10) of indocyanine green (ICG) fluorescence mapping for sentinel lymph node detection in early breast cancer [J]. Eur J Surg Oncol,2012,38(8):651-656.
[33]
Brouwer OR, Buckle T, Vermeeren L, et al. Comparing the hybrid fluorescent-radioactive tracer indocyanine green-99mTc-nanocolloid with 99mTc-nanocolloid for sentinel node identification: a validation study using lymphoscintigraphy and SPECT/CT [J]. J Nucl Med, 2012,53(7):1034-1040.
[34]
Hirano A, Kamimura M, Ogura K, et al. A comparison of indocyanine green fluorescence imaging plus blue dye and blue dye alone for sentinel node navigation surgery in breast cancer patients[J]. Ann Surg Oncol,2012,19(13):4112-4116.
[35]
van der Vorst JR, Schaafsma BE, Verbeek FP, et al. Randomized comparison of near-infrared fluorescence imaging using indocyanine green and 99(m) technetium with or without patent blue for the sentinel lymph node procedure in breast cancer patients [J]. Ann Surg Oncol,2012,19(13):4104-4111.
[36]
Schaafsma BE, van der Vorst JR, Gaarenstroom KN, et al.Randomized comparison of near-infrared fluorescence lymphatic tracers for sentinel lymph node mapping of cervical cancer [J]. Gynecol Oncol,2012,127(1):126-130.
[37]
Takeuchi M, Sugie T, Abdelazeem K, et al. Lymphatic mapping with fluorescence navigation using indocyanine green and axillary surgery in patients with primary breast cancer [J]. Breast J, 2012, 18(6):535-541.
[38]
Giammarile F, Alazraki N, Aarsvold JN, et al. The EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer[J]. Eur J Nucl Med Mol Imaging, 2013,40(12):1932-1947.
[39]
Yamamoto S, Maeda N, Yoshimura K, et al. Intraoperative detection of sentinel lymph nodes in breast cancer patients using ultrasonographyguided direct indocyanine green dye-marking by real-time virtual sonography constructed with three-dimensional computed tomographylymphography[J]. Breast,2013,22(5):933-937.
[40]
Miyashiro I, Hiratsuka M, Kishi K, et al. Intraoperative diagnosis using sentinel node biopsy with indocyanine green dye in gastric cancer surgery: an institutional trial by experienced surgeons [J]. Ann Surg Oncol,2013,20(2):542-546.
[41]
Gilmore DM, Khullar OV, Gioux S, et al. Effective low-dose escalation of indocyanine green for near-infrared fluorescent sentinel lymph node mapping in melanoma [J]. Ann Surg Oncol, 2013,20(7):2357-2363.
[42]
van der Vorst JR, Schaafsma BE, Verbeek FP, et al. Dose optimization for near-infrared fluorescence sentinel lymph node mapping in patients with melanoma[J]. Br J Dermatol,2013,168(1):93-98.
[43]
Oh Y, Quan YH, Choi Y, et al. Intraoperative combined color and fluorescent images-based sentinel node mapping in the porcine lung:comparison of indocyanine green with or without albumin premixing[J]. J Thorac Cardiovasc Surg,2013,146(6):1509-1515.
[44]
Schaafsma BE, Verbeek FP, Peters AA, et al. Near-infrared fluorescence sentinel lymph node biopsy in vulvar cancer: a randomised comparison of lymphatic tracers [J]. BJOG,2013,120(6):758-764.
[45]
Roberts HW, Donati-Bourne JF, Wilson VL, et al. The use of live fluorescence staining techniques in surgery: a review [J]. J Invest Surg,2013,26(5):283-293.
[46]
Sano K, Nakajima T, Miyazaki K, et al. Short PEG-linkers improve the performance of targeted, activatable monoclonal antibodyindocyanine green optical imaging probes [J]. Bioconjug Chem,2013,24(5):811-816.
[47]
Jain V, Phillips BT, Conkling N, et al. Sentinel lymph node detection using laser-assisted indocyanine green dye lymphangiography in patients with melanoma [J]. Int J Surg Oncol,2013,2013:904 214.
[48]
Nakamura Y, Fujisawa Y, Nakamura Y, et al. Improvement of the sentinel lymph node detection rate of cervical sentinel lymph node biopsy using real-time fluorescence navigation with indocyanine green in head and neck skin cancer[J]. J Dermatol,2013,40(6):453-457.
[49]
Schaafsma BE, Verbeek FP, Rietbergen DD, et al. Clinical trial of combined radio- and fluorescence-guided sentinel lymph node biopsy in breast cancer[J]. Br J Surg,2013,100(8):1037-1044.
[50]
Chi C, Ye J,Ding H,et al. Use of indocyanine green for detecting the sentinel lymph node in breast cancer patients: from preclinical evaluation to clinical validation[J]. PLoS One,2013,8(12):e83927.
[51]
Sugie T, Sawada T, Tagaya N, et al. Comparison of the indocyanine green fluorescence and blue dye methods in detection of sentinel lymph nodes in early-stage breast cancer [J]. Ann Surg Oncol, 2013,20(7):2213-2218.
[52]
Ballardini B, Santoro L, Sangalli C, et al. The indocyanine green method is equivalent to the 99mTc-labeled radiotracer method for identifying the sentinel node in breast cancer: a concordance and validation study [J]. Eur J Surg Oncol,2013,39(12):1332-1336.
[53]
Ahmed M, Purushotham AD, Douek M. Novel techniques for sentinel lymph node biopsy in breast cancer: a systematic review [J]. Lancet Oncol,2014,15(8):e351-e362.
[54]
Ogawa Y, Ikeda K, Ogisawa K,et al. Outcome of sentinel lymph node biopsy in breast cancer using dye alone: a single center review with a median follow-up of 5 years [J]. Surg Today, 2014, 44 (9):1633-1637.
[55]
Jung S, Kim S, Kim SW,et al. Comparison of sentinel lymph node biopsy guided by the multimodal method of indocyanine green fluorescence, radioisotope,and blue dye versus the radioisotope method in breast cancer: a randomized controlled trial [J]. Ann Surg Oncol,2014,21(4):1254-1259.
[56]
Ang CH, Tan MY, Teo C, et al. Blue dye is sufficient for sentinel lymph node biopsy in breast cancer[J]. Br J Surg, 2014, 101(4):383-389.
[57]
Lyman GH, Temin S, Edge SB, et al. Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update [J]. J Clin Oncol, 2014,32(13):1365-1383.
[58]
Verbeek FP, Troyan SL, Mieog JS, et al. Near-infrared fluorescence sentinel lymph node mapping in breast cancer:a multicenter experience[J]. Breast Cancer Res Treat,2014,143(2):333-342.
[59]
Xiong L,Gazyakan E,Yang W,et al. Indocyanine green fluorescenceguided sentinel node biopsy: A meta-analysis on detection rate and diagnostic performance[J]. Eur J Surg Oncol,2014,40(7):843-849.
[60]
Guo W, Zhang L, Ji J, et al. Breast cancer sentinel lymph node mapping using near-infrared guided indocyanine green in comparison with blue dye[J]. Tumor Biol,2014,35(4):3073-3078.
[61]
Ballardini B. Reply letter to “What is the clinical relevance of discordance between radioisotope alone and indocyanine green in sentinel lymph node biopsy for breast cancer?”[J]. Eur J Surg Oncol,2014,40(6):784-785.
[62]
Ahmed M, Douek M. What is the clinical relevance of discordance between radioisotope alone and indocynanine green in sentinel lymph node biopsy for breast cancer? [J]. Eur J Surg Oncol,2014,40(6):786.
[63]
Guo W, Zhang L, Ji J, et al. Evaluation of the benefit of using blue dye in addition to indocyanine green fluorescence for sentinel lymph node biopsy in patients with breast cancer[J]. World J Surg Oncol,2014,12:290.
[64]
Tong M, Guo W, Gao W. Use of fluorescence imaging in combination with patent blue dye versus patent blue dye alone in sentinel lymph node biopsy in breast cancer [J]. J Breast Cancer, 2014, 17(3):250-255.
[65]
Toh U, Iwakuma N, Mishima M, et al. Navigation surgery for intraoperative sentinel lymph node detection using Indocyanine green(ICG) fluorescence real-time imaging in breast cancer[J]. Breast Cancer Res Treat,2015,153(2):337-344.
[66]
Inoue T, Nishi T, Nakano Y, et al. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer[J]. Breast Cancer,2016,23(2):295-300.
[67]
Rocha A, Domínguez AM, Lécuru F, et al. Indocyanine green and infrared fluorescence in detection of sentinel lymph nodes in endometrial and cervical cancer staging - a systematic review[J]. Eur J Obstet Gynecol Reprod Biol,2016,206:213-219.
[68]
Niebling MG, Pleijhuis RG, Bastiaannet E, et al. A systematic review and meta-analyses of sentinel lymph node identification in breast cancer and melanoma,a plea for tracer mapping[J]. Eur J Surg Oncol,2016,42(4):466-473.
[69]
Ikeda T, Sugie T, Shimizu A, et al. Patterns of clinical practice for sentinel lymph node biopsy in women with node-negative breast cancer:the results of a national survey in Japan[J]. Breast Cancer,2017,24(2):341-344.
[70]
Sugie T, Kinoshita T, Masuda N, et al. Evaluation of the clinical utility of the ICG fluorescence method compared with the radioisotope method for sentinel lymph node biopsy in breast cancer [J]. Ann Surg Oncol,2016,23(1):44-50.
[71]
Zhang X, Li Y, Zhou Y, et al. Diagnostic performance of indocyanine green-guided sentinel lymph node biopsy in breast cancer: a metaanalysis[J]. PLoS One,2016,11(6):e155 597.
[72]
Arbeitsgemeinschaft Gynäkologische Onkologie (AGO). Guidelines of the AGO Breast Committee:Comission Mamma. Version 2017.1.[EB/OL]. [2017-04-10]. http:/ /www. ago-online. de/en/guidelinesmamma/april-2017/.
[73]
日本乳癌学会.乳癌診療ガイドライン[EB/OL]. [2017-04-10].http:/ /jbcs.gr.jp/guidline/guideline/.
[1] 李洋, 蔡金玉, 党晓智, 常婉英, 巨艳, 高毅, 宋宏萍. 基于深度学习的乳腺超声应变弹性图像生成模型的应用研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 563-570.
[2] 河北省抗癌协会乳腺癌专业委员会护理协作组. 乳腺癌中心静脉通路护理管理专家共识[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 321-329.
[3] 刘晨鹭, 刘洁, 张帆, 严彩英, 陈倩, 陈双庆. 增强MRI 影像组学特征生境分析在预测乳腺癌HER-2 表达状态中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 339-345.
[4] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[5] 邱琳, 刘锦辉, 组木热提·吐尔洪, 马悦心, 冷晓玲. 超声影像组学对致密型乳腺背景中非肿块型乳腺癌的诊断价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 353-360.
[6] 程燕妮, 樊菁, 肖瑶, 舒瑞, 明昊, 党晓智, 宋宏萍. 乳腺组织定位标记夹的应用与进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 361-365.
[7] 涂盛楠, 胡芬, 张娟, 蔡海峰, 杨俊泉. 天然植物提取物在乳腺癌治疗中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 366-370.
[8] 朱文婷, 顾鹏, 孙星. 非酒精性脂肪性肝病对乳腺癌发生发展及治疗的影响[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 371-375.
[9] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[10] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[11] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[12] 王玲艳, 高春晖, 冯雪园, 崔鑫淼, 刘欢, 赵文明, 张金库. 循环肿瘤细胞在乳腺癌新辅助及术后辅助治疗中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 630-633.
[13] 中国抗癌协会, 中国抗癌协会大肠癌专业委员会. 中国恶性肿瘤整合诊治指南-肛管癌(2024 版)[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 441-449.
[14] 周学锋, 董哲毅, 冯哲, 蔡广研, 陈香美. 糖尿病肾脏疾病中西医结合诊疗指南计划书[J/OL]. 中华肾病研究电子杂志, 2024, 13(06): 301-305.
[15] 李茂军, 唐彬秩, 吴青, 阳倩, 梁小明, 邹福兰, 黄蓉, 陈昌辉. 新生儿呼吸窘迫综合征的管理:多国指南/共识及RDS-NExT workshop 共识陈述简介和评价[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 607-617.
阅读次数
全文


摘要